RT Journal
A1 Strom BL, Melmon KL
T1 CAn postmarketing surveillance help to effect optimal drug therapy?
JF JAMA
JO JAMA
YR 1979
FD November 30
VO 242
IS 22
SP 2420
OP 2423
DO 10.1001/jama.1979.03300220032019
UL http://dx.doi.org/10.1001/jama.1979.03300220032019
AB Postmarketing drug surveillance (PMS) assesses the epidemiology of drug use and monitors beneficial or harmful effects of drugs following marketing. If used systematically, PMS can substantially improve drug therapy in the United States. This can be accomplished by generating information on drug use and effects otherwise unavailable, by enabling a more efficient drug approval process, and by educating drug prescribers. However, to be successful, any PMS system will need a good deal of input from such prescribers.(JAMA 242:2420-2423, 1979)